0000313143-13-000195.txt : 20131114 0000313143-13-000195.hdr.sgml : 20131114 20131114175129 ACCESSION NUMBER: 0000313143-13-000195 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131113 FILED AS OF DATE: 20131114 DATE AS OF CHANGE: 20131114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0330 BUSINESS ADDRESS: STREET 1: 400 WOOD RD CITY: BRAINTREE STATE: MA ZIP: 02184 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HANLON SUSAN M CENTRAL INDEX KEY: 0001221862 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 131221769 MAIL ADDRESS: STREET 1: HAEMONETICS CORPORATION STREET 2: 400 WOOD RD CITY: BRAINTREE STATE: MA ZIP: 02184 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2013-11-13 0 0000313143 HAEMONETICS CORP HAE 0001221862 HANLON SUSAN M 400 WOOD ROAD BRAINTREE MA 02184 0 1 0 0 VP Finance Common Stock 2013-11-13 4 S 0 1188.0 39.6201 D 16905 D Non-Qualified Stock Option (right to buy) 25.535 2008-10-24 2014-10-24 Common Stock 7138 7138 D Non-Qualified Stock Option (right to buy) 26.47 2010-10-27 2016-10-27 Common Stock 14690 14690 D Non-Qualified Stock Option (right to buy) 27.275 2009-10-22 2015-10-22 Common Stock 7206 7206 D Non-Qualified Stock Option (right to buy) 27.495 2011-10-27 2017-10-27 Common Stock 22348 22348 D Non-Qualified Stock Option (right to buy) 30.67 2012-10-25 2018-10-25 Common Stock 20726 20726 D Non-Qualified Stock Option (right to buy) 39.055 2013-10-24 2019-10-24 Common Stock 16882 16882 D Non-Qualified Stock Option (right to buy) 41.66 2014-10-23 2023-10-23 Common Stock 18456 18456 D Performance Shares 0.0 2017-03-31 2017-12-31 Common Stock 12500 12500 D Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant. Market Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Market Stock Unit based on Haemonetics stock price during the 30 trading days prior to March 31, 2017. The number of Market Stock Units (and therefore the number of shares payable) will depend on the Companys stock price during such period. The Market Stock Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to three times the target amount in column 5. The Market Stock Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d). By: Alexander Steffan For: Susan Hanlon 2013-11-14